Barclays PLC Increases Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Barclays PLC grew its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 13.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 349,112 shares of the medical instruments supplier's stock after purchasing an additional 42,303 shares during the period. Barclays PLC owned approximately 0.18% of DENTSPLY SIRONA worth $6,625,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in XRAY. Riverview Trust Co purchased a new stake in DENTSPLY SIRONA in the fourth quarter valued at about $26,000. MassMutual Private Wealth & Trust FSB raised its position in shares of DENTSPLY SIRONA by 648.4% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock valued at $27,000 after purchasing an additional 1,232 shares during the last quarter. UMB Bank n.a. boosted its stake in DENTSPLY SIRONA by 60.8% in the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock worth $28,000 after purchasing an additional 564 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. grew its position in DENTSPLY SIRONA by 700.0% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier's stock worth $33,000 after purchasing an additional 1,568 shares during the last quarter. Finally, Signaturefd LLC increased its stake in DENTSPLY SIRONA by 513.3% during the 4th quarter. Signaturefd LLC now owns 4,428 shares of the medical instruments supplier's stock valued at $84,000 after purchasing an additional 3,706 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company's stock.

Insider Buying and Selling

In other news, Director Gregory T. Lucier bought 15,142 shares of the firm's stock in a transaction dated Monday, March 3rd. The shares were acquired at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the transaction, the director now directly owns 81,971 shares in the company, valued at $1,353,341.21. The trade was a 22.66 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.52% of the stock is currently owned by insiders.

DENTSPLY SIRONA Price Performance

XRAY traded up $0.12 during midday trading on Monday, hitting $13.87. 2,260,426 shares of the company traded hands, compared to its average volume of 2,970,223. The business has a 50 day simple moving average of $15.09 and a two-hundred day simple moving average of $18.25. DENTSPLY SIRONA Inc. has a 52-week low of $12.16 and a 52-week high of $31.00. The company has a market capitalization of $2.76 billion, a price-to-earnings ratio of -6.70, a PEG ratio of 1.80 and a beta of 0.92. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 28th were paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 4.61%. The ex-dividend date of this dividend was Friday, March 28th. DENTSPLY SIRONA's dividend payout ratio is presently -14.07%.

Analyst Upgrades and Downgrades

XRAY has been the topic of a number of research analyst reports. Evercore ISI reissued an "in-line" rating and set a $20.00 price objective on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. StockNews.com lowered DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a report on Friday, February 28th. Morgan Stanley downgraded DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price for the company. in a report on Tuesday, April 15th. Wells Fargo & Company cut their price target on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating on the stock in a report on Friday, February 28th. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. Thirteen equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $22.58.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.